Skip to main content
. 2016 Aug 19;185(3):372–381. doi: 10.1111/cei.12815

Figure 3.

Figure 3

Oral but not intraperitoneal (i.p.) 4‐methylumbelliferone (4‐MU) delivery prevents autoimmunity. (a,b). Experimental autoimmune encephalomyelitis (EAE) scores of mice following treatment with 4‐MU delivered (a) in chow at 5% or (b) via daily i.p. injections of 50 mg/kg. *P < 0·05, **P < 0·01, ***P < 0·001, Mann–Whitney comparing treated mice with untreated mice (n = 5–10 animals per group).